Medtronic (MDT) Short-term Investments (2014 - 2026)

Medtronic (MDT) has 13 years of Short-term Investments data on file, last reported at $7.3 billion in Q2 2026.

• For the quarter ending Q2 2026, Short-term Investments rose 7.77% year-over-year to $7.3 billion; the trailing twelve-month figure through Apr 2026 stood at $7.3 billion (up 7.77% YoY), and the FY2026 full-year result was $7.3 billion, up 7.77% from the prior year.
• Short-term Investments steadied at $7.3 billion in Q2 2026, from $7.2 billion in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $7.7 billion in Q1 2022 to a low of $6.4 billion in Q2 2023.
• A 5-year average of $6.8 billion and a median of $6.7 billion in 2024 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments fell 19.03% in 2022 and grew 8.29% in 2026, its largest moves.
• Tracing MDT's Short-term Investments over 5 years: stood at $6.6 billion in 2022, then declined by 2.71% to $6.4 billion in 2023, then rose by 2.68% to $6.6 billion in 2024, then grew by 6.82% to $7.0 billion in 2025, then grew by 3.21% to $7.3 billion in 2026.
• Business Quant data shows MDT's Short-term Investments at $7.3 billion in Q2 2026, $7.2 billion in Q1 2026, and $7.0 billion in Q4 2025.